The transcription factor FAST-J has recently been shown to playa key role in the specification of mesoderm by TGF/3 superfamily signals in the early Xenopus embryo. We have cloned FastI, a mouse homologue of Xenopus FAST
Introduction
Members of the TGF{3 family of signaling factors have been strongly implicated in the early establishment and patterning of mesoderm in a wide range of vertebrate embryos, including frogs, mice, zebrafish, and chickens (Wall and Hogan, 1994; Seleiro et aI., 1996; Harland and Gerhart, 1997; Holley and Ferguson, 1997; Whitman, 1998) . In Xenopus, generalized inhibition of TGF{3 superfamily signaling can prevent the formation of mesoderm entirely , and ectopic activation of TGF{3 superfamily signaling by expression of either ligands or signal transducers is sufficient to induce a full range of mesodermal tissues in prospective ectoderm (Green et aI., 1992; Graff et aI., 1996; Wilson et aI., 1997) . In mice, inactivation of the embryonically expressed ligands nodal (Conlon et aI., 1994; Varlet et aI., 1997) or Bmp4 (Winnier et aI., 1995) severely disrupts establishment of the primitive streak and gastrulation. Similarly, targeted disruption of the genes encoding Type I BMP receptor (Bmpr) (Mishina et aI., 1995) , Type I activin receptor (Gu et aI., 1998) , or the signal transducers SMAD2 Waldrip et aI., 1998) or SMAD4 (Sirard et aI., 1998; Yang et aI., 1998) results in embryos that lack embryonic mesoderm. While these observations indicate that signaling by TGF{3s is essential for normal mesoderm development, the precise details of which ligands are required, when and where, is less clear (reviewed in Harland and Gerhart, 1997; Tam and Behringer, 1997) . In Xenopus, RNAs encoding a variety of TGF{3 superfamily ligands are present at stages consistent with a role in mesoderm induction or patterning, but which ligands are active and essential for each step in these processes is not known. In mice, mutant analysis of mesoderm formation is complicated by potential functional compensation among related TGF{3 family members, and by the requirement for rapid proliferation to gen-erate and maintain cell populations. Nevertheless, chimera analysis has revealed that TGF{3-related signaling is required at several stages in early development (Varlet et aI., 1997; Gu et aI., 1998; Sirard et aI., 1998; Waldrip et aI., 1998) . For example, Smad4 is initially required in extraembryonic tissues for gastrulation and mesoderm formation to proceed in the epiblast. Wild type extra-embryonic tissues can rescue gastrulation and somite formation, but not normal anterior development (Sirard et aI., 1998) .
In addition to broad conservation of many of the ligands involved in the early specification of mesoderm across vertebrates, there are extensive homologies among the genes expressed in response to mesoderm induction. Brachyury(T), for example, is expressed in the proximal epiblast and primitive streak, and is essential for the establishment of mesoderm in mice (Hermann, 1992; Wilson et aI., 1995) ; a Xenopus brachyury homolog is expressed as an early response to mesoderm induction in the frog (Smith et aI., 1991) ; and chick and Zebrafish brachyury homo logs appear to have comparable roles in early mesoderm development (Schulte-Merke et aI., 1994; Kispert et aI., 1995) . A number of other genes expressed as early responses to mesoderm inducers in the frog (e.g. gsc, xlim1) have what appear to be comparable expression patterns in other vertebrate embryos. The extent to which these broad similarities in expression, as well as detailed differences, reflect homologous underlying mechanisms of gene regulation remains an open question (reviewed in Tam and Behringer, 1997) .
One pathway by which TGF{3 superfamily ligands may regulate specific mesodermal transcriptional responses is beginning to be understood for at least a major subset of early mesodermal genes in Xenopus embryos. Dorsal mesoderm inducing factors, such as activin, Vg-l, and Xnr2, are thought to activate the receptor-regulated signal transducer Smad2 (Baker and Harland, 1996; Graff et aI., 1996) , which then forms a complex with Smad4 and the maternally encoded transcription factor FAST-l (Chen et aI., 1997) . This Smad2/Smad4/FAST -1 complex (activin responsive factor, ARF) was originally identified by its ability to bind to an enhancer element (activin responsive element, ARE) that regulates activin responsiveness of the meso-endodermal homeobox gene Mix.2 (Huang et aI., 1995) . Ectopic activation of FAST -1 is sufficient to induce expression not only of Mix. 2, but also of a broad range of activin-regulated pan-mesodermal and dorsal mesodermal genes, as well as to induce formation of a second dorsal mesodermal body axis (M. Watanabe and M. Whitman, submitted). Conversely, inhibition of FAST-l either by injection of blocking antibodies or expression of a F AST-l-Engrailed repressor fusion, prevents induction of mesodermal genes both by exogenous activin and by endogenous mesoderm inducers. These observations suggest that activation of the general TGF{3 signal transducers Smad2 and Smad4 may be coupled to specific early mesodermal responses by the transcription factor FAST-I.
Smad2 and F AST-1, as well as activin-like receptors, are expressed ubiquitously in the pre-gastrula frog embryo (Hemmati-Brivanlou et aI., 1992; Chen et aI., 1996; Graff et aI., 1996; Chang et aI., 1997) , suggesting that the specification of mesoderm is spatially restricted primarily by localization of ligand activity. In contrast, expression of Smad2 and Smad4 continues through later development, while FAST-1 transcript levels drop sharply after gastrulation (Chen et aI., 1996) . This suggests that the temporal restriction of mesoderm induction in response to TGF{3 superfamily inducers to early embryonic stages involves temporal restriction of maternal transcription factors like FAST-I.
To begin to investigate whether the regulatory pathways involved in specifying early mesoderm responses in amphibians are conserved in mammals, we report here the cloning and characterization of a mouse homologue of Xenopus FAST-I. Mouse Fast! shares important functional similarities with Xenopus F AST-1, including interaction with Smad2/Smad4 and the ARE. Fastl is expressed before the onset of gastrulation throughout the epiblast and transcript levels subsequently decline. These observations suggest that a role for FASTs as transcription factors coupling TGF{3 superfamily signals to early embryo-specific transcriptional responses may be conserved in vertebrate development.
Results

Isolation and structural characterization of a mouse FAST-1 homolog
As described in Section 4, cDNAs for human and mouse FAST-1 homologs (FASTI and FastI, respectively) were isolated and assembled by a combination of EST database searches, and cDNA and genomic library screening. Alignment of amino acid sequence predicted by the cDNAs encoding human, mouse, and Xenopus FASTs (Fig. 1 ) reveals that the overall degree of amino acid identity between the mammalian and Xenopus FASTs is not high (36% identity between Xenopus FAST-l and mouse Fast!, 32% identity between Xenopus FAST-l and human FASTl). While there is substantial similarity in the known functional domains, the forkhead DNA binding domain (65% identity between mouse and Xenopus) and the Smad interaction domain (SID) (38% identity between mouse and human), there is almost no similarity outside these regions. This is true for both mammalian versus Xenopus proteins and for human versus mouse proteins. This may reflect either a functional divergence or simply a lack of functional constraint on sequence variation in these regions.
Functional comparison of Fast1 and FAST-1
Although the sequence similarity between mouse and Xenopus FASTs suggests a common evolutionary origin and some degree of functional conservation, the limited overall sequence identity leaves open the possibility that the mouse Fastl protein diverges significantly in function from Xenopus FAST -1. We therefore examined Fast 1 for its ability to participate in the functions known for Xenopus FAST-I: (1) to participate in an ARF-like gel shift factor; (2) to specifically co-precipitate Smad2 or Smad3 and Smad
To examine the ability of mouse Fastl to participate in an ARF-like complex, 293T cells were transfected with various components of the activin signaling pathway, and extracts tested for the presence of a gel shift activity that binds to the 50 bp ARE probe (Fig. 2) . Stimulation of the pathway was provided by co-transfection of a constitutively activated form of the Type I activin receptor, ActRIB*. In the absence of transfected Fastl or ActRIB*, no ARF activity is observed; upon introduction of a eDNA encoding epitope tagged Fastl, a characteristic ARF gel shift is observed ( Fig.  2A ). That this gel shift complex contains Fastl was confirmed by antibody supershift assay; incubation of the gel shift complex with antibody directed against the epitope tag on Fastl results in a characteristic increase in mobility ofthe gel shift complex (Fig. 2B) . Similarly, supershifts using antibodies directed against epitope tags on co-expressed Smad2 and Smad4 confirm that, as for Xenopus ARF, mouse Fastl forms a DNA binding complex with Smad2 and Smad4 that recognizes the ARE (Fig. 2B ). Like Xenopus FAST-I, mouse Fastl does not bind to a probe in which a single nucleotide in the binding site has been mutated (data not shown), indicating that Xenopus FAST-I and mouse Fastl share binding site specificity. Identical results were obtained with human FAST! (not shown).
We have previously shown that FAST-I can be co-immunoprecipitated in a ligand stimulated manner with Smad4 and the activin signal transducer Smad2, but not the BMP4 signal transducer, Smadl. To address whether mouse Fastl shares both this property and signaling pathway specificity, epitope tagged Fastl was expressed in Xenopus embryos by mRNA injection, in the presence or absence of co-injection with mRNA encoding epitope tagged Smads or upstream ligands. Lysates from injected embryos were then immunoprecipitated with antibody directed against the Smad, and the immunoprecipitates blotted to detect Fastl. Fastl coprecipitates with Smad2, and this association is stimulated by activin, but does not co-precipitate with Smadl from BMP4 stimulated embryos (Fig. 3A) . Similarly, Fastl coprecipitates with Smad4 upon activin stimulation (Fig. 3B ).
These observations confirm that mouse FastI, like Xenopus FAST-I, associates specifically with Smad2 and Smad4 in an activin regulated fashion.
Interaction trap analysis of FastI -Smad interactions
As an additional comparison of the specificity of mouse Fast! interaction with Smads to that of Xenopus FAST-I, interaction between the predicted SID of mouse Fast! with the MH2 domains of various Smads was tested in the yeast interaction trap system. In this test system, the SID of mouse Fastl interacts strongly with Smad2 or Smad3, but not with Smad4 or SmadI, a pattern of specificity identical to that of Xenopus FAST-I (Fig. 4) . The interaction of the Smad3 MH2 domain with Xenopus FAST-I has not previously been examined. It is, however, consistent with the ability of Smad3, like Smad2, to incorporate into ARF, and with domains of different Smads were tested in a yeast interaction trap assay. Sequence encoding the SID of xFAST-l or mFastl was expressed as a fusion with the GAL4 DNA binding domain in the vector pGBT9 (bait), Smad MH2 domains were expressed in the activator domain fusion construct pGAD424 (fish). Interaction was measured as a ratio of i3-gal activity produced in bait + fish co-transformants to i3-gal with bait alone.
Colonies transformed with only the pGAD424 constructs showed no significant b-galactosidase activity (not shown). near identity of the Smad2 and Smad3 MH2 domains. As for Xenopus FAST-I, the association of mouse Fast! specifically with the activin signal transducers Smad2 and Smad3 appears to be driven by an interaction between the SID of Fast! and the MH2 domain of the Smads.
Transcriptional regulation by Fast1
When transfected into a variety of standard tissue culture lines, an ARE-luciferase construct is not regulated by activation of the activinlTGF,6 signaling pathway, either by the addition of ligand or by co-transfection of activated Type I receptors. When FAST -1 is co-transfected with the AREreporter construct, however, ARE-luciferase is inducible by activation of activinlTGF,6 signaling (Hayashi et aI., 1997; Liu et aI., 1997) . To examine whether mouse Fast! can confer activinlTGF,6 regulation of ARE-luciferase, cDNA encoding mouse Fastl or Xenopus FAST-l and ARE-luciferase were co-transfected into Mink lung epithelial cells with or without co-transfection of ActRIB. In the presence of mouse Fast! or Xenopus FAST-I, 3000-fold stimulation of ARE-luciferase was observed upon co-transfection of ActRIB* (Fig. 5) . Similar results were obtained using TGF,6 ligand, or when NIH 3T3 or 293 cells were used for transfection (not shown). No activation is observed when a constitutively activated Type I BMP receptor was transfected in place of ActRIB* (not shown). These observations demonstrate that mouse Fast! can functionally couple activation of an activinlTGF,6 signaling pathway to regulation of an early embryo-specific activin response element.
Expression of Fast] during mouse embryogenesis
The expression of Fastl was examined by in situ hybridization of sectioned and whole-mount embryos from pregastrulation stages (approximately 6.0 dpc) to 9.5 dpc. As shown in Fig. 6 , before gastrulation, transcripts are localized throughout the epiblast but cannot be detected in the extraembryonic ectoderm. Low levels of expression in the extraembryonic endoderm appears likely and certainly cannot be excluded. Expression remains throughout the epiblast even after gastrulation has been initiated, as judged by the expression of T in the mesoderm of the primitive streak. By the head fold stage, the level of Fastl RNA has declined but is still expressed throughout the embryo. At early somites stages (8.0 dpc, Fig. 6D) , Fast] transcripts appears to be restricted to the developing heart. This pattern of expression is retained until 8.5-9.5 dpc.
Fastl expression in P]9 and 3T3 cells
Searches of the existing EST databases revealed that cDNAs containing mouse Fastl and human FASTl sequence have to date only been found in libraries derived either from early blastocysts or embryonal carcinoma cells (data not shown). While anecdotal, these observations suggested that embryonal carcinoma cell lines might, unlike other established cell lines examined, express Fastl endogenously. To examine this possibility, Northern (Fig. 7 A) and RT PCR (Fig. 7B) analyses were done to compare expression of Fastl in an EC cell line, Pl9 with that in NIH 3T3 cells, a cell line that lacks detectable endogenous FAST -like function (by the criterion of ARE-Iuciferase responsiveness). By both detection methods, Fast] expression was detectable in Pl9 cells but not in NIH 3T3 cells. To examine whether Fastl expression was correlated with an 
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expression is detected in the primitive streak at the posterior of the embryo. (G) At 7.5 dpc, Fastl is ubiquitously expressed in the developing embryo, while T transcripts are localized to the notochord and primitive streak (H). (1,1) At 8.0 and 8.5 dpc, Fastl expression is strongest in the heart and allantois, while low levels are visible in the notochord and posterior mesoderm. Branchial arch (b); heart (h); epiblast (ep); embryonic endoderm (en); extra-embryonic ectoderm (ee); allantois (al); neural folds (nt); presomitic mesoderm (p). endogenous competence to activate ARE-Iuciferase in response to activation of activinlTGFJ3 signaling, Pl9 or NIH 3T3 cells were transfected with ARE-Iuciferase, with or without ActRIB*. Pl9 cells, but not NIH 3T3 cells, activate ARE luciferase in response to expression of ActRIB * (Fig. 7C) . NIH 3T3 cells do activate ARE-Iuciferase when co-transfected with exogenous Fastl, indicating that these cells are not lacking other signaling components necessary for regulation of ARE. The correlation of endogenous Fastl expression with endogenous capacity to activate ARE-Iuciferase is consistent with the possibility that endogenous levels of Fastl in early embryonic cells are sufficient for regulation of this activin regulated enhancer element.
Discussion
Experiments in Xenopus embryos have defined a pathway in which mesodermal cell fates can be specified by the activation of a Smad2/Smad41FAST-I coupled signaling pathway by activin, Vg1, or the Xenopus nodal homolog Xnr2 (Thomsen and Melton, 1993; Jones et aI., 1995; Baker and Harland, 1996; Graff et aI., 1996 FAST-1 expression to pre-neurula development (Chen et aI., 1996) suggests that FAST-1 may be a determinant of the transcriptional responses to TGFJ3 superfamily signals that are characteristic of early embryos and lost later in embryogenesis. That mouse Fastl shares this restriction of expression to early deve~opment, as well as ubiquitous expression in early embryonic tissues, suggests that it may also be a determinant of early embryonic competence to form mesoderm. P19 emb~y~nal carcinoma cells express mouse Fast1 and can activate the Xenopus FAST-1 reporter construct, ARE-Iuciferase, i t response to a TGFJ3 signal; these cells likewise retain th embryonic competence both to express early mesodermal. arkers in response to activin stimulation and to differentiate into mesoderm (McBurney et aI., 1982; McBurney, 1993; Vidricaire et aI., 1995) . The pluripotency of early embryonic cells is almost certainly multifactorial. However, the role of Xenopus FAST -1 in mesoderm induction (M. Watanabe and M. Whitman, submitted) and the temporal correlation of its expression with early competence (Chen et aI., 1996) , suggest that it is at least one component responsible for this phenomenon. Mouse Fast1, like Xenopus FAST-I, appears to be coupled to upstream TGFJ3 signaling through interaction with activated Smads. Both Smad2 and Smad3, but not Smad1, can interact with mouse Fastl, indicating that the ligands that activate these Smads are likely to regulate Fastl activity during embryogenesis. Smad2 and Smad3 are generally thought to be coupled primarily to signaling through TGFJ3, activin, or nodal ligands, while Smad1 is coupled to BMPs (reviewed in Heldin et aI., 1997) . During early mouse development, nodal is perhaps the best candidate for a Smad2/3-coupled ligand responsible for localized activation of Fastl Waldrip et aI., 1998) . Smad2 and Smad4 are expressed ubiquitously in the early mouse embryo, consistent with a role for these transducers in regulation of Fastl (Dick et aI., 1998; Sirard et aI., 1998; Waldrip et aI., 1998) . Nodal is dynamically expressed during early development, first transiently at low levels in the extraembryonic visceral endoderm and at higher levels in the embryonic ectoderm, becoming localized to the posterior proximal region and then in the node. Chimera analysis shows that the expression of nodal in the extra-embryonic endoderm is required for normal patterning of the anterior neural plate, while expression in at least some epiblast cells is required for primitive streak and node formation (Varlet et aI., 1997) . Chimera analysis has also established a requirement for both Smad2 and Smad4 in extra-embryonic tissues for gastrulation and embryonic mesoderm development (Sirard et aI., 1998; Waldrip et aI., 1998) . These findings raise the possibility that Fast1 functions both in the visceral endoderm and in the epiblast, to mediate signaling by nodal or as yet unidentified activin-related ligands. Testing this hypothesis must await genetic inactivation of Fastl.
The DNA binding specificity and Smad interaction specificity of mouse Fastl are indistinguishable from those of Xenopus FAST-1 by currently available criteria. The occur-rence, however, of an alternatively spliced form of Fast1 that we have not observed for Xenopus FAST-1 raises several additional possibilities. If the deletion of four amino acids from helix 2 simply renders Fastl inactive, alternative splicing may represent a mechanism for modulating Fastl function in during embryogenesis. Expression of Xenopus FAST-l from which the DNA binding domain has been deleted is actually inhibitory for activin signaling, possibly because the SID can sequester activated Smads (Chen et aI., 1997) . A DNA binding-defective Fastl might therefore not simply be inactive but act as an intracellular inhibitor of Smad 2 signals. A third possibility is that the deletion from helix 2 alters the target specificity of Fastl rather than simply eliminating DNA binding, thus modifying the set of target sites potentially regulated by Fastl. Exploration of these possibilities may lead to new insights into the role of Fastl regulation in early patterning.
The significant distance in primary sequence between them leaves open the possibility that there may be other mouse related genes that are substantially closer relatives to Xenopus FAST-l than those reported here. However, comparison of their activities in vitro assays and tissue culture cells, and their similar patterns of expression, indicate that Xenopus FAST -1 and mouse Fastl are functionally closely related in vivo. The central role of FAST-l in mesoderm specification by TGF/3 signaling in frog embryos (Watanabe and Whitman, submitted) suggests that examination of the relationship between TGF/3 superfamily ligands, Smads, and Fast 1 will an important area of investigation in the study of early mesodermal patterning in the mouse embryo.
After this manuscript was submitted, sequences were reported for mouse (Lebbe et aI., 1998) and human (Zhou et aI., 1998) homologs of Xenopus FAST-I, named FAST2 and human FAST-I, respectively. The mouse Fastl sequence reported here is identical to the sequence reported and named FAST2 by Lebbe et ai. (1998) . The human FAST 1 reported here is 99% identical to that reported for human FAST-l (Zhou et aI., 1998) .
Experimental procedures
Cloning of human and mouse FAST homologs
A BLAST (Altschul et aI., 1997) search of the human EST (expressed sequence tag) database identified an EST cloned from a human teratocarcinoma cell (NT2) cDNA library that encoded a protein sharing 48.8% amino acid identity and 65.9% similarity to the Smad Interaction Domain (SID) of Xenopus FAST-I. The cDNA corresponding to this EST sequence was obtained from I.M.A.G.E. and use as a probe to screen an NT2 cDNA library (Stratagene). A cDNA clone was isolated encoding most, but not all, of a predicted N-terminal forkhead domain, as well as a complete predicted C-terminus of a human FAST -1 homologue (FAST]). Additional sequence encoding the remaining forkhead domain was obtained by 5' Marathon RACE and outward directed PCR. Identification of amino acids conserved between F AST-l and F ASTl was used to design degenerate primers for PCR, which were used for amplification of cDNA prepared from murine embryonic stem (ES) cell mRNA (described in detail below). This amplified fragment was then used as probe to screen a day 8.5 mouse embryonic cDNA library (gift of K. Mahon, Baylor College of Medicine) and a genomic library (Stratagene). Multiple cDNA clones encoding a predicted partial mouse FAST -1 homologue was obtained, encompassing the full forkhead domain and C-terminus, but lacking a clear initiator methionine. The predicted amino-terminus was reconstructed from a genomic clone. The presence of the predicted initiator methionine and upstream stop codon in Fastl mRNA was confirmed by PCR of ES cell cDNA using primers directed against sequence contammg the initiator methionine/ upstream stop, as well as by primer extension analysis (data not shown).
Sequencing of the Fast1 cDNA revealed that the predicted amino acid sequence lacked four amino acids (position 89-92) in helix 2 of the DNA binding domain, while these amino acids were encoded in the corresponding genomic sequence. The genomic sequence contains an intron that interrupts the predicted coding sequence after codon 88. Two alternative predicted 3' splice sites yield coding sequence either containing or lacking sequence encoding amino acids 89-92. PCR amplification analysis of the forkhead domain of Fast 1 from ES cell cDNA yielded fragments encoding protein that included amino acids 88-92; semiquantitative PCR analysis of ES cell cDNA demonstrated that forkhead sequence containing amino acids 88-92 is the predominant splice form in ES cells. Expression of the two splice forms by in vitro translation or mRNA injection into Xenopus embryos demonstrated that the protein lacking amino acids 89-92 fails to bind DNA and cannot confer ARE responsiveness (not shown), while the isoform containing these amino acids does. cDNA encoding Fastl containing amino acids 89-92 was used for the studies reported here.
Degenerate PCR cloning of a Fast1 fragment
Regions of amino acid sequence conserved between human FASTI and Xenopus FAST-l were used to design degenerate primers for nested PCR of poly A + cDNA prepared from ES cell RNA. Primer pairs were: first round: 5'-AARGAYWSNATHMGNCAYAA and 5'-ANAYNS-WYTTRTTNGGNGG-3'; second round: 5'-CARGCNAA-RG GNAAYTTYTGG-3' and 5'-GNGGCATNACNAC-RTTNGG-3'. Total cDNA was amplified for 35 cycles with first round primers, at an annealing temperature of 48°C, then diluted 1 :200 and amplified for an additional 25 cycles with the second round primers. A single product of approximately 600 bp was obtained, subcloned, sequenced, and used as a probe for screening of the mouse cDNA library.
Yeast interaction trap analysis
Yeast two-hybrid assays were performed as previously described (Chen et aI., 1997) . The GAL4-DNA-binding domain in the pGBT9 vector was fused to a region of hFAST that encompassed the SID (specifically, from aa25S to the C terminus). Similarly, the SID of Fastl (beginning at aa311 and continuing to the C-terminus) was cloned into the pGBT9 vector. These constructs were, respectively, tested for interaction with the Smad2 MH2 domain (aa24S-aa467), the Smadl MH2 domain (aa249-aa465), the Smad3 MH2 domain (aa 242-aa446), the Smad4 MH2 domain (aa306-aa54S), and the full-length Smad4 protein (aalaa54S), each one fused to the GAL4-activation domain in the pGAD424 vector.
Isolation of embryonic stem cell (ES) and embryonic
RNA
Total RNA was isolated using a LiCl/urea method from undifferentiated ES cells and ICR embryos between 7.5 and 17.5 days post coitus (dpc; 1200 h on day of the plug is 0.5 dpc) (Winnier et aI., 1995) . The ES cells were derived from the TLl line which were cultured for two passages in the absence of mouse embryo fibroblasts, and embryos of each stage were pooled together.
RT-PCR analysis of FastI expression
Total RNA was extracted from NIH 3T3 and P19 cells, respectively, using Trisolv (Biotecx, Houston, TX). RT-PCR was performed as previously described using aezP]dCTP (LaBonne and Whitman, 1994) . PCR conditions for amplification of Fastl were as follows: 94°C, 3 min (1 cycle); 60°C, 1 min; noc, 1 min; 94°C, 1 min (IS cycles); 60°C, 30 s; noc, 10 min (1 cycle). PCR primers used were as follows: 5' -CCACAATCAT AGAGGGGGAGAGTTC-3' and 5'-TCTTACTTGCCCATCTATACGCCCA-3'. PCR conditions for amplification of mouse GAPDH (internal control) were identical to those conditions used for amplification of Fastl. The number of cycles used for GAPDH was 20. The following are the sequences of the oligos used to amplify GAPDH: 5'-CTGACGTGCCGCCTGGA-GAAA-3' and 5'-TGTTGGGGGCCGAGTTGGGA T AG-3'. Northern analysis of Fastl expression Total RNA was extracted from NIH 3T3 and P19 cells, respectively, using Trisolv (Biotecx, Houston, TX). Poly-A + RNAs were then extracted using the Oligotex mRNA kit (Qiagen, Chatsworth, CA). Approximately 10 /lg poly-A + RNAs were electrophoresed on an ethidium bromide (EtBr)-stained gel, and 15 /lg total RNA were run in adjacent lanes for size comparison using the 2SS and ISS ribosomal RNAs.
Northern analysis was performed according to standard methodology, as outlined in Sambrook et aI. (1990) . A cDNA probe corresponding to a region of Fastl spanning the linker region was labeled with aezP]dCTP (3000 Ci/ mmol) using a Random Primed DNA Labeling Kit (New England Nuclear, Boston, MA). The probe was originally generated by PCR amplification from a random-and oligo dT-primed mouse cDNA IZAPII library (obtained from Chris Wright). This PCR product was subcloned into a pCS2MT vector, excised, and gel-purified in preparation for Random Primed DNA labeling. Degenerate oligos used for the primary round of amplification: 5'-AAR-GAYWSNATHMGNCAYAA-3' and 5'-ANAYNSWYT-TRTTNGGNGG-3'. Degenerate oligos used for the secondary round of amplification: 5'-CARGCNAARGGNAAYT-TYTGG-3' and 5'-GNGGCATNACNACRTTNGG-3'.
An aezP]dCTP-Iabeled mouse GAPDH probe was used as an internal control. This probe was PCR amplified from reverse transcribed mouse ES cell cDNA, using the same oligos used to amplify GAPDH in RT-PCR reactions (see above).
In situ hybridizations
Whole-mount in situ hybridizations were performed as described by Winnier et aI. (1995) . The murine T (1.4 kb) and FastI (O.Skb) cDNAs were used as templates for synthesizing antisense or sense strand digoxygenin labeled riboprobes. In situ hybridization with 35S-aUTP RNA probes was performed using a protocol previously described by Zhou et aI. (1993) , using the sense and antisense probes described above.
EMSA and co-immunoprecipitation
EMSA and supershift assays were performed as described (Huang et aI., 1995; Chen et aI., 1996; Chen et aI., 1997) . Co-immunoprecipitations (CO-IP) were carried out as previously described (Chen et aI., 1997) . Electrophoresis of samples, transfer to nitrocellulose, and detection by ECL were performed as described (LaBonne et aI., 1995) .
Tissue culture and transient transfections
Embryonic mouse teratocarcinoma (PI9) cells were obtained from ATCC and maintained in DMEM (Cell Grow) with 7.5% iron supplemented calf serum and 2.5% fetal calf serum (Hyclone). Mink lung epithelial (CCL64 clone L-17) and NIH 3T3 cells were maintained in DMEM supplemented with 10% fetal calf serum and 100 units/ml each of penicillin and streptomycin (GIBCO-BRL). The human fetal kidney cell lines (293 and 293T) were maintained in DMEM supplemented with 10% calf serum, and 100 units/ml each of penicillin and streptomycin. The cells were split to 6 cm dishes at a density of 1 x 105 cells/dish 24 h prior to transfection. The L-17 cells were transfected by the indicated plasmids using the DEAE-dex-tran method (Kingston et al., 1993) . The P19, 293 and 293T cells were transfected by the CaP0 4 (2 x HBS) method (Sambrook et aI., 1990) . The 3T3 cells were transfected using the Superfect system as directed (Qiagen).
Luciferase assays
Thirty-six hours following transfection the cells were placed in media containing 0.2% serum for 12-14 h. Forty-eight hours following transfection the cells were placed on ice, the media was aspirated and the cells were washed with 2 ml of cold PBS. The cells were harvested by scraping into 1 ml of ice-cold PBS, then pelleted by centrifugation at 2000 x g for 3 min at 4°C and the PBS was removed by aspiration. The L-17 and 3T3 cells were lysed in 200 J.tl, and the P19 cells in 100 J.tl of buffer B (25 mM Tris-HCI (pH 7.4),125 mM NaCI, 1 mM MgCI 2 , 1 % Triton X-lOO) supplemented with 1 mM DTT, 25 mM b-glycerophosphate, 100 J.tM sodium orthovanadate, 1 % phenylmethyl sulfonyl fluoride, 10 J.tg/ml aprotinin, and 10 J.tg/ml leupeptin, placed on ice for 10 min with occasional vortexing. The cells were spun at 15000 x g for 10 min and 20 J.tl of the supernatant was reserved for the determination of protein concentration by the Lowry method. To determine the Luciferase activity typically 20 J.tl of cell extract was combined with 100 J.tl of Luciferase assay reagent (Promega) for 1 min at room temp. (and assayed in a liquid scintillation counter for 2 min).
